Obstetrics and Gynecology Archives
Dec. 7, 2017—Vanderbilt University Medical Center (VUMC) is one of 24 institutions nationwide seeking to reduce the incidence of primary cesarean births through an initiative sponsored by the American College of Nurse-Midwives (ACNM).
Jul. 20, 2017—Vanderbilt University Medical Center is currently enrolling women to participate in a study looking at the drug Montelukast to treat interstitial cystitis/bladder pain syndrome (IC/BPS).
Jun. 29, 2017—Renewal House and Vanderbilt University Medical Center (VUMC) have launched an alliance that will expedite treatment and expand the community’s capacity to treat mothers and children most acutely affected by opioid addiction in the mid-state.
VUMC study shows cesarean patients sent home from hospital with more narcotic pain medications than needed
Jun. 13, 2017—Most women who undergo a cesarean childbirth are prescribed more opioid (narcotic) pain medications than needed upon release from the hospital, a Vanderbilt University Medical Center study shows.
Jun. 7, 2017—A 10-year study, led by Vanderbilt University Medical Center professor of Obstetrics and Gynecology Katherine Hartmann, M.D., Ph.D., disrupts conventional wisdom that uterine fibroids cause miscarriages.
May. 4, 2017—Kevin Osteen, Ph.D., Pierre Soupart Professor Obstetrics and Gynecology, and his team at the Women’s Reproductive Health Research Center have developed a three-dimensional organ-on-a-chip cell model that mimics the endometrial lining of the uterus in an effort to test therapeutic interventions for reproductive diseases.
Jan. 12, 2017—Genetic counselors are playing a greater role in areas of medicine in the wake of advancement in genomic technology.
Nov. 3, 2016—Vanderbilt University Medical Center’s (VUMC) Center for Women’s Health has launched a new clinic with the opening of the Center for Vulvar and Vaginal Disorders.
Oct. 17, 2016—Ronald Alvarez, new professor of obstetrics and gynecology and chair of the department, is a leading expert in the field of clinical gene therapy for ovarian and cervical cancers.